Skip to main content
Log in

Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Antiphospholipid syndrome (APS) is a cause of infertility and fetal loss. Ovarian stimulation can induce previously unknown APS. Ovarian hyperstimulation syndrome (OHS) is uncommon but potentially life-threatening, as well as catastrophic APS. A woman that simultaneously developed a severe OHS and a catastrophic APS is described in this paper. Both entities produced thrombotic cardiac and brain thrombosis. A peculiar mechanism of cardiac ischemia is also described. In spite of the life-threatening risk of this situation, the indication for preventive anti-aggregation and/or anticoagulation is not clear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Egbase PE (2000) Severe OHSS: how many cases are preventable? Hum Reprod 15(1):8–10

    Article  PubMed  CAS  Google Scholar 

  2. Delvigue A, Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Updat 8(6):559–577

    Article  Google Scholar 

  3. Murdoch AP, Evbuomwan I (1999) Severe complications of ovarian hyperestimulation syndrome are preventable. Hum Reprod 14(11):2922–2924

    Article  PubMed  CAS  Google Scholar 

  4. Balasch J, Fabreques F, Arroyo V (1998) Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperestimulation syndrome. Hum Reprod 13:2718–2730

    Article  PubMed  CAS  Google Scholar 

  5. Vinatier D, Dufour P, Cosson M, Houpeau JL (2001) Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 96(1):37–50

    Article  PubMed  CAS  Google Scholar 

  6. Balasch J, Creus M, Fabregues F, Reverter JC, Carmona F, Tassies B, Font J, Vanrell JA (1996) Antiphospholipid antibodies and human reproductive failure. Hum Reprod 11(10):2310–2315

    PubMed  CAS  Google Scholar 

  7. Luzzana C, Gerosa M, Riboldi P, Meroni PL (2002) Update on the anti-phospholipid syndrome. J Nephrol 15:342–348

    Article  PubMed  Google Scholar 

  8. Meyer O (2003) Hormonal life in systemic lupus and other connective tissue diseases. Gynecol Obstet Fertil 31(9):746–756

    Article  PubMed  CAS  Google Scholar 

  9. Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD (2000) Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 43(3):550–556

    Article  PubMed  CAS  Google Scholar 

  10. Huong du LT, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoa Lefebvre G, Piette JC (2002) Importance of planning ovulation induction therapy in systemic erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum 32(3):174–188

    Article  PubMed  Google Scholar 

  11. Koo EJ, Rha JH, Lee BI, Kim MO, Ha CK (2002) A case of cerebral infarct in combined Antiphospholipid Antibody and Ovarian Hyperstimulation Syndrome. J Korean Med Sci 17:574–576

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Giner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giner, V., Oltra, M.R., Esteban, M.J. et al. Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation. Clin Rheumatol 26, 991–993 (2007). https://doi.org/10.1007/s10067-006-0231-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0231-4

Keywords

Navigation